These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36219364)

  • 1. Diminished PD-L1 regulation along with dysregulated T lymphocyte subsets and chemokine in ANCA-associated vasculitis.
    Singh J; Minz RW; Saikia B; Nada R; Sharma A; Jha S; Anand S; Rathi M; D'Cruz S
    Clin Exp Med; 2023 Sep; 23(5):1801-1813. PubMed ID: 36219364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.
    Zeisbrich M; Chevalier N; Sehnert B; Rizzi M; Venhoff N; Thiel J; Voll RE
    Front Immunol; 2021; 12():673912. PubMed ID: 34108971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Loss of Immune Checkpoint Programmed Cell Death Protein 1 and Active ANCA-Associated Renal Vasculitis.
    Hakroush S; Tampe B
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
    de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
    Brix SR; Stege G; Disteldorf E; Hoxha E; Krebs C; Krohn S; Otto B; Klätschke K; Herden E; Heymann F; Lira SA; Tacke F; Wolf G; Busch M; Jabs WJ; Özcan F; Keller F; Beige J; Wagner K; Helmchen U; Noriega M; Wiech T; Panzer U; Stahl RA
    J Am Soc Nephrol; 2015 Sep; 26(9):2105-17. PubMed ID: 25762060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
    Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
    Front Immunol; 2021; 12():737708. PubMed ID: 34759920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered circulating CCR6
    Liao Z; Tang J; Luo L; Deng S; Luo L; Wang F; Yuan X; Hu X; Feng J; Li X
    Arthritis Res Ther; 2021 Jul; 23(1):194. PubMed ID: 34289887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    Hakroush S; Tampe B
    J Nephrol; 2022 May; 35(4):1177-1183. PubMed ID: 34851509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis.
    Miyabe C; Dong Y; Ikeda T; Takahashi K; Miyabe Y; Kawakami T
    Sci Rep; 2021 Oct; 11(1):20019. PubMed ID: 34625602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.
    Zhang H; Watanabe R; Berry GJ; Vaglio A; Liao YJ; Warrington KJ; Goronzy JJ; Weyand CM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E970-E979. PubMed ID: 28115719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
    Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
    J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.
    Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M
    Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis.
    Liu J; Song K; Lin B; Chen Z; Zuo Z; Fang Y; He Q; Yao X; Liu Z; Huang Q; Guo X
    Int Immunopharmacol; 2024 May; 133():112130. PubMed ID: 38648712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CXCL5 inhibits tumor immune of lung cancer via modulating PD1/PD-L1 signaling].
    Xie XH; Wang YJ; Lei W; Gao HJ; Duan YJ; Hou X
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):382-388. PubMed ID: 35615793
    [No Abstract]   [Full Text] [Related]  

  • 20. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.